Gene892
CCNC: cyclin C
Cite this record
ConductScience Library. CCNC: cyclin C. Genes, record 892. Release gene-search-2026-11-13-0.2.1, 13 Nov 2026. https://conductscience.org/library/genes/892
- Sources
- 13 sources
- Release
- gene-search-2026-11-13-0.2.1
Gene
Proteins1
Reviewed human proteins whose Swiss-Prot entry states the gene.
| UniProt entry | Protein | Length | Structures | Gene stated in |
|---|---|---|---|---|
| P24863 | Cyclin-C | 283 | 36 | Ensembl, GeneID, HGNC |
Source UniProt
Patents63
Patents whose sequence listing contains this protein's exact sequence. A patent can list a sequence without claiming it.
| Publication | Published | SEQ ID NO | Protein | Source |
|---|---|---|---|---|
| US 20260139223 A1 | 2026-05-21 | 73 | P24863 | Espacenet |
| EP 4650780 A2 | 2025-11-19 | 15184 | P24863 | Espacenet |
| US 20250320254 A1 | 2025-10-16 | 15184 | P24863 | Espacenet |
| JP 2025517970 A | 2025-06-12 | 15184 | P24863 | Espacenet |
| US 20250074962 A1 | 2025-03-06 | 5714 | P24863 | Espacenet |
| US 20240398993 A1 | 2024-12-05 | 21908 | P24863 | Espacenet |
| JP 2024123008 A | 2024-09-10 | 5714 | P24863 | Espacenet |
| US 20240285795 A1 | 2024-08-29 | 153673 | P24863 | Espacenet |
| US 20230026259 A1 | 2023-01-26 | 20995 | P24863 | Espacenet |
| US 11446398 B2 | 2022-09-20 | 20995 | P24863 | Espacenet |
NIH grants797
NIH grants whose papers are about the gene, through NIH's grant-paper links.
| Grant | Title | CCNC papers | Newest fiscal year |
|---|---|---|---|
| P30CA008748 | Cancer Center Support Grant | 8 | 2025 |
| P30CA016672 | Cancer Center Support Grant | 6 | 2025 |
| P30CA046934 | University of Colorado Cancer Center Support Grant | 6 | 2025 |
| P40OD018537 | Bloomington Drosophila Stock Center at Indiana University | 5 | 2025 |
| R01HD087417 | Molecular basis of MED12 in the pathogenesis of uterine fibroids | 5 | 2025 |
| P30CA021765 | Cancer Center Support Grant (CCSG) | 4 | 2025 |
| R01DK110063 | Discordant transcriptional regulation of gluconeogenic and lipogenic gene expression | 4 | 2025 |
| R35GM139550 | Mechanisms of RNA polymerase II transcription regulation | 4 | 2025 |
| P30CA036727 | Buffett Cancer Center Support Grant | 3 | 2025 |
| P30DK020541 | NYR-Diabetes Research Center (NYR-DRC) | 3 | 2025 |
Source NIH's project files
Papers1,090
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Cyclin C nuclear release and mitochondrial dysfunction define molecular signatures of MED13L syndrome. | HGG Adv | 2026 | 42698208 | PubTator, text mining | PubMed |
| Targeting epigenetic regulators induces transcription-replication conflicts to overcome ATR inhibitor resistance. | Nucleic Acids Res | 2026 | 42621735 | PubTator, text mining | PubMed |
| Synthesis and antitumoral evaluation of 3',4'-unsaturated nucleoside analogues bearing a chlorinated remdesivir-like base. | Bioorg Chem | 2026 | 42607445 | PubTator, text mining | PubMed |
| Discovery of a potent dual-target CDK8 and cyclin C PROTAC degrader for the treatment of colorectal cancer. | RSC Med Chem | 2026 | 42519713 | PubTator, text mining | PubMed |
| ClSAMBA regulates ray floret growth and flowering time in Chrysanthemum lavandulifolium. | Plant Sci | 2026 | 42419490 | PubTator, text mining | PubMed |
Reply to Small, K.W. Comment on "Spedicati et al. Hidden in the Genome: The First Italian Family with North Carolina Macular Dystrophy Carrying a Novel PRDM13 and CCNC Duplication. Biomedicines 2025, 13, 1904". | Biomedicines | 2026 | 42351656 | PubTator, text mining | PubMed |
| Comment on Spedicati et al. Hidden in the Genome: The First Italian Family with North Carolina Macular Dystrophy Carrying a Novel PRDM13 and CCNC Duplication. Biomedicines 2025, 13, 1904. | Biomedicines | 2026 | 42351654 | PubTator, text mining | PubMed |
| The Role of the Mediator Complex in Modulating CjXDR1-Induced Multidrug Resistance and Virulence in Clarireedia jacksonii. | Phytopathology | 2026 | 42308477 | PubTator, text mining | PubMed |
| Amplification of MED30 at chromosome 8q24 reprograms MYC binding to low-affinity oncogenic enhancers in cancer cells. | Cell Rep | 2026 | 42275218 | PubTator, text mining | PubMed |
| The Cyclin C-CDK8/19 Mediator kinase module controls PRCC-TFE3 driven senescence in renal epithelium and tumorigenesis in TFE3-RCC. | Neoplasia | 2026 | 41843980 | PubTator, text mining | PubMed |
None in this release
- Drugs
- Trials
Sources 13
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
- USPTO's sequence listingsPublic domain in the US. Source: United States Patent and Trademark Office, www.uspto.gov
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
- USPTO's sequence listingsUSPTO's sequence listings of patents and published applications, from its bulk data files. No license named for the files. USPTO's terms say "most government-produced materials appearing on this website are not subject to copyright restrictions within the United States and are therefore in the public domain", and ask that USPTO be given appropriate acknowledgement ("Source: United States Patent and Trademark Office, www.uspto.gov"). USPTO does not endorse ConductScience or this release. Read on 12 Nov 2026 at https://www.uspto.gov/terms-use-uspto-websites
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
Source: United States Patent and Trademark Office, www.uspto.gov. USPTO does not endorse ConductScience or this database.
For software
Read this gene from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/genes/v1/892
GET https://conductscience.org/api/genes/v1/892/patents?page=2